Mepacrine in recalcitrant cutaneous lupus erythematosus: old-fashioned or still useful?
Zitieren Sie bitte immer diese URN: urn:nbn:de:bvb:20-opus-149181
- Treatment of recalcitrant cutaneous lupus erythematosus (CLE) is challenging. In situations where conventional treatment approaches fail mepacrine - an antimalarial/antiinfiammatory drug that has fallen into oblivion in the last decades might still be a promising option. We retrospectively analysed medical records of 10 patients with refractory CLE that were treated with mepacrine (100-200 mg/day) as mono- or combination therapy for various time intervals between 2001 and 2013 at the University Hospital Wurzburg. Mepacrine was generally wellTreatment of recalcitrant cutaneous lupus erythematosus (CLE) is challenging. In situations where conventional treatment approaches fail mepacrine - an antimalarial/antiinfiammatory drug that has fallen into oblivion in the last decades might still be a promising option. We retrospectively analysed medical records of 10 patients with refractory CLE that were treated with mepacrine (100-200 mg/day) as mono- or combination therapy for various time intervals between 2001 and 2013 at the University Hospital Wurzburg. Mepacrine was generally well tolerated. Side effects were mild and usually resolved after reduction or cessation. Over 50% of the patients experienced amelioration of their symptoms despite a previously recalcitrant clinical course. Altogether, our data demonstrate that mepacrine still remains a useful and effective therapeutic option for otherwise treatment-resistant CLE.…
Autor(en): | Sandrine Benoit, Matthias Goebeler |
---|---|
URN: | urn:nbn:de:bvb:20-opus-149181 |
Dokumentart: | Artikel / Aufsatz in einer Zeitschrift |
Institute der Universität: | Medizinische Fakultät / Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie |
Sprache der Veröffentlichung: | Englisch |
Titel des übergeordneten Werkes / der Zeitschrift (Englisch): | Acta Dermato-Venereologica |
Erscheinungsjahr: | 2015 |
Band / Jahrgang: | 95 |
Seitenangabe: | 596-599 |
Originalveröffentlichung / Quelle: | Acta Dermato-Venereologica 2015; 95: 596–599. DOI: 10.2340/00015555-2031 |
DOI: | https://doi.org/10.2340/00015555-2031 |
Allgemeine fachliche Zuordnung (DDC-Klassifikation): | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
Freie Schlagwort(e): | classification; cutaneous lupus erythematosus; mepacrine; quinacrine; smoking; therapy |
Datum der Freischaltung: | 27.11.2018 |
Lizenz (Deutsch): | CC BY-NC: Creative-Commons-Lizenz: Namensnennung, Nicht kommerziell 4.0 International |